Osteoarthritis: Pathophysiology

Osteoarthritis: Pathophysiology - Joint Failure Unveiled

Osteoarthritis (OA) is a progressive "whole joint" disease, not just wear and tear, leading to joint failure.

• Core Pathology: Progressive loss of articular cartilage.
• Key Features:
  • Subchondral bone sclerosis & cyst formation.
  • Synovitis (inflammation of synovium).
  • Meniscal degeneration (knee).
  • Ligamentous laxity.
• Types:
  • Primary OA: Idiopathic, most common, often age-related.
  • Secondary OA: Due to a known cause (e.g., trauma, other arthritis).

⭐ OA is the most common form of arthritis worldwide, affecting millions and a leading cause of disability in the elderly.

Osteoarthritis: Pathophysiology - The Matrix Mission

OA: progressive articular cartilage degradation from chondrocyte dysfunction and extracellular matrix (ECM) breakdown, overwhelming repair.

• Chondrocyte Dysfunction:
  • Key features: Senescence, apoptosis, altered phenotype (hypertrophic-like).
  • Imbalance: ↑ Catabolic enzymes (MMPs, ADAMTS); ↓ anabolic (matrix synthesis) activity.
• ECM Degradation:
  • Targets: Collagen type II (structural), Aggrecan (compressive).
  • Enzymes: MMPs (e.g., MMP-13) degrade collagen; ADAMTS (e.g., ADAMTS-5) degrade aggrecan.
• Failed Repair Mechanisms:
  • Ineffective chondrocyte repair, forms mechanically inferior fibrocartilage.

Cartilage Structural Changes:

• Early Changes:
  • Fibrillation (superficial cracks/fraying).
  • Swelling (↑ water content, initial ↓ proteoglycans).
• Late Changes:
  • Erosion (progressive cartilage loss).
  • Eburnation (subchondral bone polished, dense, sclerotic).

⭐ Loss of proteoglycans is an early event leading to increased water content and reduced stiffness in cartilage.

Osteoarthritis: Pathophysiology - The Angry Neighbors

• Subchondral Bone Remodeling: "The stressed foundation."
  • Sclerosis: ↑ bone density beneath cartilage, appears whiter on X-ray.
  • Cysts: Fluid-filled cavities within subchondral bone.
  • Osteophytes: Marginal bony outgrowths; body's attempt to ↑ joint surface area and stabilize.

    ⭐ Osteophytes are attempts at repair and stabilization but can cause pain and restrict motion.

  • Bone marrow lesions (BMLs): Associated with pain, reflect inflammation/edema.
• Synovitis: The Inflamed Lining: "Low-grade, chronic fire."
  • Synovial hypertrophy and low-grade inflammation.
  • Key pro-inflammatory cytokines: Interleukin-1β (IL-1β), Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6).
  • Innate immune cells, especially macrophages, contribute to inflammation.
• Cartilage-Bone-Synovium Crosstalk: "A dysfunctional neighborhood."
  • A complex interplay: damage in one tissue (cartilage, bone, synovium) affects others.
  • Cartilage degradation products (e.g., fibronectin fragments) trigger synovial inflammation.
  • Synovium releases catabolic enzymes (MMPs) and cytokines, further damaging cartilage and bone.
  • Altered subchondral bone mechanics impact overlying cartilage integrity.

Osteoarthritis: Pathophysiology - The Destructive Orchestra

Osteoarthritis (OA) features progressive articular cartilage loss from an imbalance between destructive and reparative processes, orchestrated by molecular mediators and key risk factors.

• Key Molecular Mediators:

  • Enzymes (Catabolic):
    • Matrix Metalloproteinases (MMPs): MMP-1, MMP-3, MMP-13 (collagenase-3) degrade Type II collagen.
    • ADAMTS (Aggrecanases): ADAMTS-4, ADAMTS-5 cleave aggrecan.
  • Pro-inflammatory Cytokines: IL-1β, TNF-α drive inflammation and matrix degradation.
  • Chemokines: Attract inflammatory cells to the joint.
  • Growth Factors: TGF-β exhibits a complex role (repair vs. fibrosis).

• Influential Risk Factors:

  • Age: Associated with chondrocyte senescence and ↓ repair capacity.
  • Obesity: ↑ Mechanical stress + metabolic inflammation via adipokines (e.g., leptin).
  • Genetics: e.g., mutations in collagen genes (COL2A1), GDF5.
  • Trauma/Joint Injury: Initiates degenerative changes (post-traumatic OA).
  • Mechanical Stress/Malalignment: Leads to abnormal joint load distribution.

⭐ MMP-13 (collagenase-3) is a key enzyme responsible for Type II collagen degradation in OA.

High‑Yield Points - ⚡ Biggest Takeaways

• Articular cartilage degradation is the hallmark, driven by chondrocyte dysfunction and an imbalance in matrix synthesis and breakdown.
• Key enzymes like Matrix Metalloproteinases (MMPs) and ADAMTS degrade collagen type II and aggrecan.
• Subchondral bone sclerosis, cyst formation, and marginal osteophyte development are characteristic structural changes.
• Low-grade synovial inflammation (synovitis), mediated by cytokines like IL-1β and TNF-α, contributes to pain and progression.
• Mechanical stress, aging, genetics, and obesity are significant risk factors.
• Progressive loss of cartilage integrity leads to joint space narrowing and functional impairment.
• Chondrocyte apoptosis and altered signaling pathways further exacerbate cartilage damage.